Medtronic plc (NYSE:MDT) had an volatile session and gained 0.19 points till last call. The price was at $85.89, gaining 0.22% till the last intraday data. The total uptick value was $48.83 million while the total downtick value was $58.68 million. The shares saw a net money flow of $(-9.85) million and the up/down ratio stood at 0.83. The stock has seen a change of of 3.56% for the week. The share had a block transaction during the course of trading in which the net money flow was $(-9.76) million. Almost $0 million were received in upticks and approximately $9.76 million were lost in downticks, thereby giving the up/down ratio of 0.
Currently the company Insiders own 0.21% of Medtronic plc shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -4.03% . Institutional Investors own 82.76% of Medtronic plc shares. During last six month period, the net percent change held by insiders has seen a change of -5.04%. On the companys insider trading activities, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the officer (SrVP & Chief Scien, Clin, Reg) of Medtronic Plc, Kuntz Richard had sold 49,905 shares worth of $4,122,153 in a transaction dated June 3, 2016. In this transaction, 49,905 shares were sold at $82.6 per share.
Medtronic plc (NYSE:MDT) witnessed a volatile trading activity on Monday and eventually ended flat at 0% or 0 points without letting the bulls or bears take much advantage. The trading began at $85.42 and reached the intraday high at $86.31. The bulls started the profit booking and pushed the shares to intraday low of $85.42. The trading session was marked by a volume range of 5,395,492 shares exchanging hands. The 52-week high of the shares is $86.31 and the 52-week low is $55.54. The market cap of the company stands at $154,349 million and there are 1,801,043,300 shares in public circulation.
Many analysts have stated their opinion on the company shares. Guggenheim Securities initiates coverage on Medtronic plc (NYSE:MDT). According to the latest information available, the shares are now rated Neutral by the analysts at the agency. The rating by the firm was issued on June 9, 2016.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.